Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 16, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Pf-04531083

Email this page to a colleague

« Back to Dashboard

What is the drug development status for Pf-04531083?

Pf-04531083 is an investigational drug.

There have been 6 clinical trials for Pf-04531083. The most recent clinical trial was a Phase 1 trial, which was initiated on October 1^st 2011.

The most common disease conditions in clinical trials are Chronic Pain, Toothache, and [disabled in preview]. The leading clinical trial sponsors are Pfizer and [disabled in preview].

Summary for Pf-04531083

US Patents	0
International Patents	0
US Patent Applications	74
WIPO Patent Applications	37
Japanese Patent Applications	15
Clinical Trial Progress	Phase 1 (2011-10-01)
Vendors	16

Recent Clinical Trials for Pf-04531083

Title	Sponsor	Phase
Efficacy Of Pf-04531083 In Treating Post-Surgical Dental Pain	Pfizer	Phase 2
Study To Assess The Effect Of PF-04531083 On Heat Pain In Healthy Volunteers With Ultraviolet Light Sensitized Skin	Pfizer	Phase 1
A Study To Observe The Performance Of A Tablet Form Of PF-04531083 As Evidenced By The Concentration Of PF-04531083 In The Blood With Time Following Oral Administration To Healthy Volunteers.	Pfizer	Phase 1

See all Pf-04531083 clinical trials

Clinical Trial Summary for Pf-04531083

Top disease conditions for Pf-04531083

Top clinical trial sponsors for Pf-04531083

See all Pf-04531083 clinical trials

US Patents for Pf-04531083

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

McKinsey

AstraZeneca

Baxter

Boehringer Ingelheim

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.